Results
eNauka >
Results >
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial
| Title: | Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial | Authors  : | Howard, James; ...; Perk, Stojan; ...; (broj, koautora 16) | Issue Date: | 2021 | Publication: | LANCET NEUROLOGY | ISSN: | 1474-4422 Lancet Neurology Search Idenfier |
Type: | Article | Collation: | vol. 20 br. 7 str. 526-536 | DOI: | 10.1016/S1474-4422(21)00159-9 | WoS-ID: | 000687268300012 | Scopus-ID: | 2-s2.0-85107960986 | URI: | https://enauka.gov.rs/handle/123456789/822732 | Project: | argenx | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21a+M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.